Chromosome 13 deletion isnot effective on overall survival (OS) and progression-free survival (PFS) of H-MM patients (10).Decreases in miRNA-24, -152 and -425 increasethe expression of CCND1, fibroblast growth factorreceptor 3 (FGFR3), transforming acidic coiledcoil-containing protein 3 (TACC3) and masculoaponeuroticfibrosarcoma oncogene homolog B(MAFB) genes in H-MM (45). The gene discussed is FGFR3; the disease is Miyoshi myopathy.